North America Keratosis Pilaris Treatment Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
North America Keratosis Pilaris Treatment Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
North America Keratosis Pilaris Treatment Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| North America Keratosis Pilaris Treatment Total | $ 2218.65 Million | $ 2776.49 Million | $ 4350.15 Million | 5.773% |
| United States | $ 1879.2 Million | $ 2342.24 Million | $ 3638.03 Million | 5.658% |
| Canada | $ 199.68 Million | $ 257.94 Million | $ 431.1 Million | 6.631% |
| Mexico | $ 139.78 Million | $ 176.31 Million | $ 281.02 Million | 6.001% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Modality breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the Keratosis Pilaris Treatment Market
The presence of key players such as pharmaceutical companies, skincare brands, and dermatology clinics characterizes the competitive landscape of the Keratosis Pilaris Treatment market. These entities compete through product innovation, strategic partnerships, and marketing efforts to gain market share and address the unmet needs of patients with Keratosis Pilaris.
Keratosis Pilaris Treatment Industry News
In December 2022, Biofrontera AG commercially launched AMELUZ in Finland. This product launch can be used in line with the European approval for the treatment of actinic keratoses and basal cell carcinoma with the BF-RhodoLED lamp as part of conventional photodynamic therapy or as daylight therapy. This strategy helped the company enhance its product offerings as well as strengthen its geographical presence in Europe.
In December 2020, Almirall received FDA approval for Klisyri (tirbanibulin), a new innovative topical treatment for actinic keratosis. This product approval helped the company to enhance its actinin keratosis product portfolio and reach untapped economies, thereby increasing its customer base.
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global Keratosis Pilaris Treatment market size was estimated at USD XX Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031. In North America, the Keratosis Pilaris Treatment market is primarily driven by factors such as a high prevalence of the condition, increasing awareness among patients and healthcare providers, and a strong emphasis on skincare and aesthetics. Additionally, advancements in dermatological research and technology contribute to the development of innovative treatment options. Furthermore, the presence of well-established healthcare infrastructure and reimbursement systems enhances accessibility to treatment, driving market growth in the region.
Country Analysis
- According to Cognitive Market Research, the US had a major share in the Keratosis Pilaris Treatment market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The availability of a wide range of treatment options, including prescription medications, over-the-counter products, and procedural interventions, contributes to the growth of the market by catering to diverse patient needs and preferences.
- The Canada Keratosis Pilaris Treatment market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Favorable reimbursement policies and government initiatives aimed at improving dermatological care further stimulate the market.
- The Mexico Keratosis Pilaris Treatment market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD XX million in 2024.
The pharmaceutical and healthcare industry is growing rapidly, driven by aging populations, chronic disease prevalence, and rising healthcare spending. Innovations in precision medicine, gene therapy, and digital health are improving outcomes, though challenges include high R&D costs, strict regulations, and pricing pressures. Growth opportunities lie in emerging markets with expanding healthcare infrastructure, while key trends such as AI-driven personalized medicine, telehealth, and sustainable pharma solutions are reshaping the industry.
Analyst Conclusion
- Author Says: North America held the major market of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
- The over-the-counter (OTC) segment of the Keratosis Pilaris Treatment market comprises non-prescription products such as moisturizers, exfoliants, and creams available directly to consumers without a prescription. This segment caters to individuals seeking self-management options and milder symptom relief, providing convenience and accessibility in managing Keratosis Pilaris.
- Increasing awareness about skincare, rising prevalence of skin conditions, advancements in dermatological treatments, growing demand for non-invasive procedures, expanding geriatric population
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
Frequently Asked Questions
★ Reviews
Rate this report
North America Keratosis Pilaris Treatment Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Modality | Over-the-Counter, Prescription |
|---|---|
| Treatment Type | Topical Exfoliates, Topical Retinoid, Laser Treatment, Others |
| Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| End User | Individuals, Dermatology Clinics, Beauty Salons and Spa, Others |
| List of Competitors | DERMAdoctor, First Aid Beauty (P&G), CeraVe (L'Oréal), SLMD Skincare, Paulaâ€s Choice, AmLactin (Novartis), Eucerin (Beiersdorf AG), Nip + Fab, Touch Skin Care |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 DERMAdoctor
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 First Aid Beauty (P&G)
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 CeraVe (L'Oréal)
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 SLMD Skincare
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Paulaâ€s Choice
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 AmLactin (Novartis)
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 Eucerin (Beiersdorf AG)
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Nip + Fab
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 Touch Skin Care
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.1 DERMAdoctor
- 1.1 Top Competitors Analysis
Chapter 2. Global Keratosis Pilaris Treatment Market Analysis
- 2.1 Global Keratosis Pilaris Treatment Market Analysis
- 2.2 Global Keratosis Pilaris Treatment Market Analysis by Modality
- 2.3 Global Keratosis Pilaris Treatment Market Analysis by Treatment Type
- 2.4 Global Keratosis Pilaris Treatment Market Analysis by Distribution Channel
- 2.5 Global Keratosis Pilaris Treatment Market Analysis by End User
Chapter 3. North America Keratosis Pilaris Treatment Market Analysis
- 3.1 North America Keratosis Pilaris Treatment Market Analysis
- 3.2 North America Keratosis Pilaris Treatment Market Analysis by Country
- 3.3 North America Keratosis Pilaris Treatment Market Analysis by Modality
- 3.4 North America Keratosis Pilaris Treatment Market Analysis by Treatment Type
- 3.5 North America Keratosis Pilaris Treatment Market Analysis by Distribution Channel
- 3.6 North America Keratosis Pilaris Treatment Market Analysis by End User
- 3.7 North America Keratosis Pilaris Treatment Market Analysis by Key Players
Chapter 4. United States Keratosis Pilaris Treatment Market Analysis
- 4.1 United States Keratosis Pilaris Treatment Market Analysis
- 4.2 United States Keratosis Pilaris Treatment Market Analysis by Modality
- 4.3 United States Keratosis Pilaris Treatment Market Analysis by Treatment Type
- 4.4 United States Keratosis Pilaris Treatment Market Analysis by Distribution Channel
- 4.5 United States Keratosis Pilaris Treatment Market Analysis by End User
- 4.6 United States Keratosis Pilaris Treatment Market Analysis by Key Players
Chapter 5. Canada Keratosis Pilaris Treatment Market Analysis
- 5.1 Canada Keratosis Pilaris Treatment Market Analysis
- 5.2 Canada Keratosis Pilaris Treatment Market Analysis by Modality
- 5.3 Canada Keratosis Pilaris Treatment Market Analysis by Treatment Type
- 5.4 Canada Keratosis Pilaris Treatment Market Analysis by Distribution Channel
- 5.5 Canada Keratosis Pilaris Treatment Market Analysis by End User
- 5.6 Canada Keratosis Pilaris Treatment Market Analysis by Key Players
Chapter 6. Mexico Keratosis Pilaris Treatment Market Analysis
- 6.1 Mexico Keratosis Pilaris Treatment Market Analysis
- 6.2 Mexico Keratosis Pilaris Treatment Market Analysis by Modality
- 6.3 Mexico Keratosis Pilaris Treatment Market Analysis by Treatment Type
- 6.4 Mexico Keratosis Pilaris Treatment Market Analysis by Distribution Channel
- 6.5 Mexico Keratosis Pilaris Treatment Market Analysis by End User
- 6.6 Mexico Keratosis Pilaris Treatment Market Analysis by Key Players
Chapter 7. Modality Analysis
- 7.1 Over-the-Counter
- 7.2 Prescription
Chapter 8. Treatment Type Analysis
- 8.1 Topical Exfoliates
- 8.2 Topical Retinoid
- 8.3 Laser Treatment
- 8.4 Others
Chapter 9. Distribution Channel Analysis
- 9.1 Hospital Pharmacies
- 9.2 Retail Pharmacies
- 9.3 Online Pharmacies
Chapter 10. End User Analysis
- 10.1 Individuals
- 10.2 Dermatology Clinics
- 10.3 Beauty Salons and Spa
- 10.4 Others
Chapter 11. Qualitative Analysis (Subject to Data Availability)
- 11.1 Market Drivers
- 11.2 Market Restraints
- 11.3 Market Trends
- 11.4 Market Opportunity
- 11.5 Technological Road Map (Subject to Data Availability)
- 11.6 Product Life Cycle (Subject to Data Availability)
- 11.7 Customer and Buyer Behavior Analysis
- 11.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 11.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 11.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 11.7.4 Pricing, Affordability & Value Perception Analysis
- 11.7.5 Customer Segmentation & Demand Pattern Analysis
- 11.8 Industrial Chain Analysis (Subject to Data Availability)
- 11.8.1 Industry Chain Analysis
- 11.8.2 Manufacturing Cost Analysis
- 11.8.3 Supply Side Analysis
- 11.8.3.1 Raw Material Analysis
- 11.8.3.2 Raw Material Procurement Analysis
- 11.8.3.3 Raw Material Price Trend Analysis
- 11.9 PESTEL Analysis
- 11.9.1 Environmental Factors
- 11.9.2 Legal Factors
- 11.9.3 Technological Factors
- 11.9.4 Economic Factors
- 11.9.5 Political Factors
- 11.9.6 Social Factors
- 11.10 Porter’s Five Forces Analysis
- 11.10.1 Degree of Competition
- 11.10.2 Threat of Substitutes
- 11.10.3 Threat of New Entrants
- 11.10.4 Bargaining Power of Buyers
- 11.10.5 Bargaining Power of Suppliers
- 11.11 Patent Analysis (Subject to Data Availability)
- 11.12 ESG Analysis
- 11.13 Geopolitical Outlook
- 11.13.1 Global Power Realignment & Strategic Alliances
- 11.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 11.13.3 International Trade Relations & Market Access Environment
- 11.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 11.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 11.13.6 Technology Sovereignty & Digital Geopolitics
- 11.13.7 Strategic Implications for Investment, Growth & Market Entry
- 11.14 AI & Market Transformation
- 11.14.1 Competitive Landscape Disruption & Strategic Shifts
- 11.14.2 AI-Driven Transformation of Industry Value Chain
- 11.14.3 Evolution of Business Models & Revenue Streams
- 11.14.4 AI-Driven Product, Service & Innovation Transformation
- 11.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 12. Research Findings
- 12.1 Key Takeaways
- 12.2 Analyst Point of View
- 12.3 Assumptions and Acronyms
Chapter 13. Research Methodology and Sources
- 13.1 Primary Data Collection
- 13.1.1 Steps for Primary Data Collection
- 13.1.1.1 Identification of KOL
- 13.1.2 Backward Integration
- 13.1.3 Forward Integration
- 13.1.4 How Primary Research Help Us
- 13.1.5 Modes of Primary Research
- 13.1.1 Steps for Primary Data Collection
- 13.2 Secondary Research
- 13.2.1 How Secondary Research Help Us
- 13.2.2 Sources of Secondary Research
- 13.3 Data Validation
- 13.3.1 Data Triangulation
- 13.4 Data Representation
- 13.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the North America Keratosis Pilaris Treatment Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Pharma and Healthcare Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the North America Keratosis Pilaris Treatment Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the north america keratosis pilaris treatment market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
